Int. J. Mol. Sci. 2011, 12(5), 3191-3204; doi:10.3390/ijms12053191
Article

KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues

1 Department of Cellular Biology, Center Hospital University, Montpellier 34000, France 2 University of Montpellier I, Montpellier 34000, France 3 Department of Pathology, Center Hospital University, Montpellier 34000, France 4 Department of Biology, Centre Lutte Contre Cancer Val d’Aurelle, Montpellier 34000, France
* Author to whom correspondence should be addressed.
Received: 25 March 2011; in revised form: 11 April 2011 / Accepted: 5 May 2011 / Published: 17 May 2011
(This article belongs to the Section Molecular Diagnostics)
PDF Full-text Download PDF Full-Text [505 KB, Updated Version, uploaded 18 May 2011 08:27 CEST]
The original version is still available [516 KB, uploaded 17 May 2011 14:29 CEST]
Abstract: KRAS mutation has been unambiguously identified as a marker of resistance to cetuximab-based treatment in metastatic colorectal cancer (mCRC) patients. However, most studies of KRAS mutation analysis have been performed using homogenously archived CRC specimens, and studies that compare freshly frozen specimens and formalin-fixed paraffin-embedded (FFPE) specimens of CRC are lacking. The aim of the present study was to evaluate the impact of tissue preservation on the determination of KRAS mutational status. A series of 131 mCRC fresh-frozen tissues were first analyzed using both high-resolution melting (HRM) and direct sequencing. KRAS mutations were found in 47/131 (35.8%) using both approaches. Out of the 47 samples that were positive for KRAS mutations, 33 had available matched FFPE specimens. Using HRM, 2/33 (6%) demonstrated suboptimal template amplification, and 2/33 (6%) expressed an erroneous wild-type KRAS profile. Using direct sequencing, 6/33 (18.1%) displayed a wild-type KRAS status, and 3/33 (9.1%) showed discordant mutations. Finally, the detection of KRAS mutations was lower among the FFPE samples compared with the freshly frozen samples, demonstrating that tissue processing clearly impacts the accuracy of KRAS genotyping.
Keywords: genotyping; KRAS; fixative

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Solassol, J.; Ramos, J.; Crapez, E.; Saifi, M.; Mangé, A.; Vianès, E.; Lamy, P.-J.; Costes, V.; Maudelonde, T. KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues. Int. J. Mol. Sci. 2011, 12, 3191-3204.

AMA Style

Solassol J, Ramos J, Crapez E, Saifi M, Mangé A, Vianès E, Lamy P-J, Costes V, Maudelonde T. KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues. International Journal of Molecular Sciences. 2011; 12(5):3191-3204.

Chicago/Turabian Style

Solassol, Jérome; Ramos, Jeanne; Crapez, Evelyne; Saifi, Majda; Mangé, Alain; Vianès, Evelyne; Lamy, Pierre-Jean; Costes, Valérie; Maudelonde, Thierry. 2011. "KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues." Int. J. Mol. Sci. 12, no. 5: 3191-3204.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert